Tremeau Pharmaceuticals

Tremeau Pharmaceuticals

Pharmaceuticals, 53 Main St, Concord, Massachusetts, 01742, United States, 11-50 Employees

tremeaurx.com

  • twitter
  • LinkedIn

phone no Phone Number: 64********

Who is TREMEAU PHARMACEUTICALS

Tremeau is a Massachusetts-based pharmaceutical company focused on providing non-opioid pain treatments for well-defined patient populations with significant unmet needs. Tremeaus unique ...

Read More

map
  • 53 Main St, Concord, Massachusetts, 01742, United States Headquarters: 53 Main St, Concord, Massachusetts, 01742, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from TREMEAU PHARMACEUTICALS

Tremeau Pharmaceuticals Org Chart and Mapping

Employees

Corey Macgregor

Vice President, New Products Planning and Business Development

Chris Fanale

Head of Marketing, Medical Affairs, & Operations

Lori Sorial

Senior Manager, Regulatory Affairs and Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Tremeau Pharmaceuticals

Answer: Tremeau Pharmaceuticals's headquarters are located at 53 Main St, Concord, Massachusetts, 01742, United States

Answer: Tremeau Pharmaceuticals's phone number is 64********

Answer: Tremeau Pharmaceuticals's official website is https://tremeaurx.com

Answer: Tremeau Pharmaceuticals's revenue is $5 Million to $10 Million

Answer: Tremeau Pharmaceuticals's SIC: 2834

Answer: Tremeau Pharmaceuticals has 11-50 employees

Answer: Tremeau Pharmaceuticals is in Pharmaceuticals

Answer: Tremeau Pharmaceuticals contact info: Phone number: 64******** Website: https://tremeaurx.com

Answer: Tremeau is a Massachusetts-based pharmaceutical company focused on providing non-opioid pain treatments for well-defined patient populations with significant unmet needs. Tremeaus unique approach to acute and chronic pain in select conditions is rooted in the mechanism of action, documented efficacy, and clinically differentiated profile of COX-2 selective NSAIDs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access